Corium International, Inc.

 
Corium International, Inc. is a leader in applying advanced transdermal delivery systems and related technologies to address unmet medical needs. We have developed two highly differentiated state of the art transdermal technologies:
  • MicroCor®, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines large molecules that require active transport through the skin
  • Corplex™, a novel adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver
With a team that includes the innovators of many of the market-leading transdermal products, Corium combines great technologies with a strong track record of successfully designing, developing and producing therapeutic products.
 

Corium News

 
Date Title and Summary View
Sep 17, 2014 MENLO PARK, Calif., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the appointment of Paul Goddard, Ph.D. to the Company's Board of Directors. "We are pleased...
PDF
Aug 12, 2014 MENLO PARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited results from operations for both the third fiscal quarter and the nine months ended Ju...
PDF

Copyright ©2006-2014 Corium International, Inc.